Back to Search Start Over

To Tweet or Not to Tweet: A Longitudinal Analysis of Social Media Use by Global Diabetes Researchers.

Authors :
Leigh S
Noble ME
Pearson FE
Iremonger J
Williams DT
Source :
Pharmaceutical medicine [Pharmaceut Med] 2021 Nov; Vol. 35 (6), pp. 353-365. Date of Electronic Publication: 2021 Dec 07.
Publication Year :
2021

Abstract

Background: Engaging influential stakeholders in meaningful exchange is essential for pharmaceutical companies aiming to improve care. At a time where opportunities for face-to-face engagement are limited, the ability to interact, learn and generate actionable insights through digital channels such as Twitter, is of considerable value.<br />Aim: The aim of this study was to evaluate digital engagement among global diabetes mellitus researchers.<br />Materials and Methods: We identified every global tweet (20,614,515) and scientific publication (44,135) regarding diabetes mellitus from 1 August 2018 to 1 August 2020. Through author matching we combined datasets, resulting in a list of digitally active scientific authors. Generalised linear modelling identified factors predicting their digital engagement.<br />Findings: Globally, 2686 diabetes researchers used Twitter to discuss the management of diabetes mellitus, posting 110,346 diabetes-related tweets. As Twitter followers increased, so did tweet frequency (p < 0.001), retweets (p < 0.001) and replies (p < 0.001) to their content. Publication count (overall/per month) and proportion of first/last authorships were unrelated to tweet frequency and the likelihood of being retweeted or replied to (p > 0.05). Those with the most  academic co-authors were significantly less likely to tweet than those with smaller networks (< 50; p = 0.001). Finally, those publishing most frequently on specific themes, including insulin (p = 0.041) and paediatrics (p < 0.001), were significantly more likely to tweet about these themes.<br />Conclusion: Academic expertise and seniority cannot be assumed as proxies for digital influence. Those aiming to promote science and obtain digital insights regarding condition management should consider looking beyond well-known 'key opinion leaders' to perhaps lesser known 'digital opinion leaders' with smaller academic networks, who are likely to specialise in the delivery of highly specific content to captive audiences.<br /> (© 2021. The Author(s).)

Details

Language :
English
ISSN :
1179-1993
Volume :
35
Issue :
6
Database :
MEDLINE
Journal :
Pharmaceutical medicine
Publication Type :
Academic Journal
Accession number :
34874534
Full Text :
https://doi.org/10.1007/s40290-021-00408-6